Subchronic oral toxicity assessment of N-acetyl-l-aspartic acid in rats

Food and Chemical Toxicology

Volumn 49, Issue 1, 2011, Pages 155-165

  Karaman, Sule ^a   Barnett Jr , John ^b   Sykes, Greg P ^c   Delaney, Bryan ^a  

^a PIONEER HI BRED INTERNATIONAL INC   (United States)

^b CHARLES RIVER LABORATORIES   (United States)

^c DUPONT COMPANY   (United States)

Author keywords

Food; L aspartate; N acetyl l aspartate; Oral administration; Subchronic toxicity

Indexed keywords

N ACETYLASPARTIC ACID;

ACINAR CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ENLARGEMENT; CHRONIC TOXICITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; FEMALE; FOOD INTAKE; FOOD POISONING; MALE; NONHUMAN; RAT; SALIVARY GLAND; SUBCHRONIC TOXICITY; SURVIVAL RATE; TOXICITY TESTING;

ANIMALS; ASPARTIC ACID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MOTOR ACTIVITY; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; URINALYSIS;

RATTUS;

EID: 78650281761     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2010.10.011     Document Type: Article

References (58)

1. Akimitsu T., Kurisu K., Hanaya R., Iida K., Kiura Y., Arita K., Matsubayashi H., Ishihara K., Kitada K., Serikawa T., Serikawa T., Sasa M. Epileptic seizures induced by N-acetyl-l-aspartate in rats: in vivo and in vitro studies. Brain Res. 2000, 861:143-150.
2. Baslow M.H. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem. Res. 2003, 28:941-953.
3. Berlinguet L., Laliberte M. Metabolism of N-acetyl-l-aspartic acid in mice. Can. J. Biochem. 1966, 44:783-789.
4. Buchner A., Sreebny L.M. Enlargement of salivary glands. Review of the literature. Oral Surg. Oral Med. Oral Pathol. 1972, 34:209-222.
5. Burdock G.A., Flamm W.G., Carabin I.G. Toxicity and mutagenicity studies of DN-50000((R)) and RP-1((R)) enzymes. Food Chem. Toxicol. 2000, 38:429-442.
6. Burlina A.P., Ferrari V., Divry P., Gradaowska W., Jakobs C., Bennett M.J., Sewell A.C., Dionic-Vici C., Burlina A.B. N-acetylaspartylglutamate in Canavan disease: an adverse effector?. Eur. J. Pediatr. 1999, 158:406-409.
7. Chakraborty G., Mekala P., Yahya D., Wu G., Ledeen R.W. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J. Neurochem. 2001, 78:736-745.
8. Cox G.J., Clements W.G., Hilger E.C., Degrange D.W. Enlargement of submandibular salivary glands of rats restricted to acidic and basic solutions as the sole source of drinking fluid. J. Dent. Res. 1957, 36:576-580.
9. Crofton K.M., Howard J.L., Moser V.V., Gill M.W., Reiter L.W., Tilson H.A., MacPhail R.C. Interlaboratory comparison of motor activity experiments: implication for neurotoxicological assessments. Neurotoxicol. Teratol. 1991, 13:599-609.
10. Delaney B. Acute oral toxicity of N-acetyl-l-aspartic acid (NAA) in rats. Food Chem. Toxicol. 2010, 48:1761.
11. Delaney B., Amanda Shen Z., Powley C.R., Gannon S., Munley S.A., Maxwell C., Barnett J.F. Acute and repeated dose oral toxicity of N-acetyl-l-aspartic acid in Sprague-Dawley rats. Food Chem. Toxicol. 2008, 46:2023-2034.
12. Ershoff B.H., Levin E. An orally-active, heat-labile factor in pancreas which induces salivary gland hypertrophy in rats. Proc. Soc. Exp. Biol. Med. 1962, 110:262-265.
13. Giardina T., Biagini A., Massey-Haroche D., Puigserver A. Distribution and subcellular localization of acylpeptide hydrolase and acylase I along the hog gastro-intestinal tract. Biochimie 1999, 81:1049-1055.
14. Haggerty G.C. Development of tier I neurobehavioral testing capabilities for incorporation into pivotal rodent safety assessment studies. J. Am. Coll. Toxicol. 1989, 8:53-69.
15. Hershfield J.R., Madhavarao C.N., Moffet J.R., Benjamins J.A., Garbern J.Y., Nambodiri A. Aspartoacylase is a regulated nuclear-cytoplasmic enzyme. FASEB J. 2006, 20:E1482-E1492.
16. Hershfield J.R., Pattabiraman N., Madhavarao C.N., Namboodiri A. Mutational analysis of aspartoacylase: implications for Canavan disease. Brain Res. 2007, 1148:1-14.
17. Hession A., Esrey E., Croes R., Maxwell C. N-acetylaspartate and N-acetylglutamate in Soybeans (Glycine max (L.) Merr.), Maize (Zea maize L.) and Other Foodstuffs. J. Agric. Food Chem. 2008, 56:9121-9126.
18. Ikeda R., Aiyama S. Developmental changes of sugar residues and secretory protein in mucous cells of the early postnatal rat parotid gland. Anat. Rec. 1999, 255:155-161.
19. Irwin S. Comprehensive observational assessment: Ia - A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 1968, 13:222-257.
20. Johnson D.A., Sreebny L.M. Effects of increasing the bulk content of the diet on the rat parotid gland and the saliva. J. Dent. Res. 1982, 61:691-696.
21. Kamoshita S., Rapin I., Suzuki K. Spongy degeneration of the brain: a chemical study of two cases including isolation and characterization of myelin. Neurology 1968, 18:975-986.
22. Karaman S., Myhre A., Donner M., Munley S., Delaney B. Mutagenicity studies with N-acetyl-l-aspartic acid. Food Chem. Toxicol. 2009, 47:1936-1940.
23. Karelson G., Ziegler A., Künnecke B., Seelig J. Feeding versus infusion: a novel approach to study the NAA metabolism in rat brain. NMR Biomed. 2003, 16:413-423.
24. Kaul R., Rao G.P., Balamurugan K., Matalon R. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Nat. Genet. 1993, 5:118-123.
25. Kikuchi K., Aiyama S., Ikeda R., Matsuoka T., Takada K. Granule types and their morphological changes in terminal cluster and acinar cells in the late pre- and early postnatal rat sublingual gland. Anat. Rec. Part A 2004, 277A:209-215.
26. Kirmani B.F., Jacobowitz D.M., Kallarakal A.T., Namboodiri M.A. Aspartoacylase is restricted primarily to myelin synthesizing cells in the CNS: therapeutic implications for Canavan disease. Brain Res. Mol. Brain Res. 2002, 107:176-182.
27. Kitada K., Akimitsu T., Shigematsu Y., Kondo A., Maihara T., Yokoi N., Kuramoto T., Sasa M., Serikawa T. Accumulation of N-acetyl-l-aspartate in the brain of the tremor rat, a mutant exhibiting absence-like seizure and spongiform degeneration in the central nervous system. J. Neurochem. 2000, 74:2512-2519.
28. Klaassen C.D. Principles of toxicology. Casarett and Doull's Toxicology - The Basic Science of Poisons 1986, 12. Macmillan Publishing Company, New York, NY. third ed. C.D. Klaassen, M.O. Amdur, J. Doull (Eds.).
29. Kumar S., Mattan N.S., de Vellis J. Canavan disease: a white matter disorder. Ment. Retard. Dev Disabil. Res. Rev. 2006, 12:157-165.
30. Madhavarao C.N., Arun P., Moffett J.R., Szucs S., Surendran S., Metalon R., Garbern J., Hristova D., Johnson A., Jiang W., Namboodiri M.A.A. Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. Proc Natl. Acad. Sci. USA 2005, 102:5221-5226.
31. MAFF, 1999. Japanese Ministry of Agriculture, Forestry and Fisheries. Good Laboratory Practice Standards. 11 Nousan No. 6283.
32. Mehta V., Namboodiri M.A. N-acetylaspartate as an acetyl source in the nervous system. Brain Res. Mol. Brain Res. 1995, 31:151-157.
33. Miyake M., Kakimoto Y., Sorimachi M. A gas chromatographic method for the determination of N-acetyl-l-aspartic acid, N-acetyl-alpha-aspartylglutamic acid and beta-citryl-l-glutamic acid and their distributions in the brain and other organs of various species of animals. J. Neurochem. 1981, 36:804-810.
34. Moffett J.R., Ross B., Arun P., Madhavarao C.N., Namboodiri A.M. N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog Neurobiol. 2007, 81:89-131.
35. Moser V.C. Screening approaches to neurotoxicity: a functional observational battery. J. Am. Coll. Toxicol. 1989, 8:85-93.
36. Muramatsu K., Odagiri H., Morishita S., Takeuchi H. Effects of excess levels of individual amino acids on growth of rats fed casein diets. J. Nutr. 1971, 101:1117-1126.
37. Namboodiri A.M., Peethambaran A., Mathew R., Sambhu P.A., Hershfield J., Moffet J.R., Madhavarao C.N. Canavan disease and the role of N-acetyl-l-aspartate in myelin synthesis. Mol. Cell. Endocrinol. 2006, 252:216-223.
38. NRC Institute of Laboratory Animal Resources Commission on Life Sciences and the National Research Council. Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington, DC.
39. O'Donoghue J.L. Screening for neurotoxicity using a neurologically based examination and neuropathology. J. Am. Coll. Toxicol. 1989, 8:97-115.
40. OECD, 1998. Repeated dose 90-day oral toxicity study in rodents, No. 408 section 4 Health Effects. Organisation for Economic Co-operation and Development, last update September 21, 1998.
41. OECD Principles of good laboratory practices, [C(97)186/Final] (1998); Environmental Health and Safety Division. OECD Environment Directorate.
42. Patel T.B., Clark J.B. Synthesis of N-acetyl-l-aspartate by rat brain mitochondria and its involvement in mitochondrial/cytosolic carbon transport. Biochem. J. 1979, 184:539-546.
43. Schainker B., Olney J.W. Glutamate-type hypothalamic-pituitary syndrome in mice treated with aspartate or cysteate in infancy. J. Neural Transm. 1974, 35:207-215.
44. Schneyer C.A. Salivary gland changes after isoproterenol-induced enlargement. Am. J. Physiol. 1962, 203:232-236.
45. Sinichkin A., Sterri S., Edminson P.D., Reichelt K.L., Kvamme E. In vivo labeling of acetyl aspartyl peptides in mouse brain from intracranially and intraperitoneally administered acetyl-l-[U-14C]aspartate. J. Neurochem. 1977, 29:425-431.
46. Stegink L.D. Absorption, utilization, and safety of aspartic acid. J. Toxicol. Environ. Health 1976, 2:215-242.
47. Tada Y., Yano N., Takahashi H., Yuzawa K., Ando H., Kubo Y., Nagasawa A., Uehara S., Ogata A., Nakae D. Toxic effects of l-aspartic acid at high dose levels on kidneys and salivary glands in Fischer 344 rats detected in a 90-day feeding study. Food Chem. Toxicol. 2008, 46:2789-2795.
48. Tallan H.H., Moore S., Stein W.H. N-acetyl-l-aspartic acid in brain. J. Biol. Chem. 1956, 1:257-264.
49. Truckenmiller M.E., Namboodiri M.A., Brownstein M.J., Neale J.H. N-acetylation of l-aspartate in the nervous system: differential distribution of a specific enzyme. J. Neurochem. 1985, 45:1658-1662.
50. Tsai G., Coyle J.T. N-acetylaspartate in neuropsychiatric disorders. Prog. Neurobiol. 1995, 46:531-540.
51. U.S. EPA, 1989. Federal Insecticide, Fungicide and Rodenticide Act/Toxic Substances Control Act (FIFRA/TSCA); Good Laboratory Practice Standards; Final Rule. 40 CFR Part 160/Part 792.
52. Wells H. Submandibular salivary gland weight increase by administration of isoproterenol to rats. Am. J. Physiol. 1962, 202:425-428.
53. Wells H. Salivary gland enlargement after administration of theophylline. Am. J. Physiol. 1967, 212:1293-1296.
54. Wells H., Peronace A.A.V. Synergistic autonomic nervous regulation of accelerated salivary gland growth in rats. Am. J. Physiol. 1964, 207:313-318.
55. Wells H., Peronace A.A.V. Functional hypertrophy and atrophy of the salivary glands of rats. Am. J. Physiol. 1967, 212:247-251.
56. Wells H., Voelkel E.F. Submandibular salivary gland enlargement by feeding pancreatin to rats. Am. J. Physiol. 1963, 205:1117-1121.
57. Wells H., Peronace A.A.V., Stark L.W. Taste receptors and sialadenotrophic action of proteolytic enzymes in rats. Am. J. Physiol. 1965, 208:877-881.
58. Zeng B.J., Wang Z.H., Ribeiro L.A., Leone P., De Gasperi R., Kim S.J.M., Raghavan S., Ong E., Pastores G.M., Kolodny E.H. Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease. J. Inher. Metabol. Dis. 2002, 25:557-570.